MEDICA 2023 + COMPAMED 2023 Show the Way Forward in Healthcare
By LabMedica International staff writers Posted on 13 Nov 2023 |

An audience of medical professionals from across the world and all areas of the healthcare economy is coming together once again in Düsseldorf, Germany as the internationally leading medical trade fair MEDICA (Düsseldorf, Germany) kicks off on November 13 to 16, 2023, with an unprecedented number of participants including over 5,300 companies from close to 70 countries. COMPAMED, which is held in parallel, is the international leading trade fair for suppliers within the medical technology industry, where about 730 companies from 39 countries are participating. After German companies, the largest bookings of floor space has been from China, Italy, Turkey, South Korea, the USA and other European nations such as France, Spain, the United Kingdom and Poland. At COMPAMED, the USA, Italy and Switzerland are at the top behind Germany.
In the halls of the trade fair grounds, exhibitors are presenting a comprehensive range of medical products, devices and instruments for outpatient and clinical treatment which covers all phases of development, production and marketing. MEDICA determines its focus areas in its five worlds of experience covering the huge range of over 10,000 company innovations related to lab technology and diagnostics, medical technology and electromedicine, commodities and consumables, physiotherapy and orthopedic technology as well as IT systems and IT solutions. The highlights of each MEDICA, in addition to the numerous innovations, traditionally also include multi-faceted accompanying programs with celebrity visits and presentations. Moreover, the keynote speakers are expected to particularly spice up the specialist topics.
The on-stage program of the accompanying conferences and the professional forums integrated into the worlds of experience is offering several other highlights. These include the finals of two start-up competitions on the stage of the MEDICA CONNECTED HEALTHCARE FORUM (Hall 12). At the 12th MEDICA Start-up COMPETITION on Tuesday afternoon (14 November), the focus is on the entire spectrum of innovations for the healthcare sector: from artificial intelligence (AI) to health apps, solutions for laboratory diagnostics and medical robotics. For the first time this year, “sustainability” features as a novel category. The 15th “Healthcare Innovation Worldcup” on Monday afternoon (13 November), by contrast, focuses on intelligent “Internet of Medical Things” (IoMT) solutions such as digital biomarkers, smart bandages and network-connectible wearables.
A key trend currently shaping the market is the growing trend of “outpatientisation”. This puts the focus on “point-of-care” products and services that includes patient-oriented diagnostics and treatment, as well as telemedical applications for optimal, cross-sector networking among all those involved in the care process. Other current key trends are procedures based on artificial intelligence (AI) and supporting systems, such as robotic systems or VR/AR (virtual reality/augmented reality) applications, as well as solutions for the implementation of more sustainable processes along the supply and added value chain.
At COMPAMED 2023 in the trade fair Halls 8a and 8b, medical technology industry suppliers are showing what they are capable of. The exhibiting companies are also presenting (five) worlds of experience including a wide range of high-tech and service solutions. The five worlds of experience are: Manufacturing & Devices (e.g., components, parts, manufacturing processes), Services & Advice (e.g., research, development, services), Materials (e.g., plastics, glass, ceramics, metals, composite materials, adhesives, packaging), Micro Tech (such as micro components, microfluidics) as well as IT in Tech (software development and maintenance for medical technology). The program sessions, the COMPAMED HIGH-TECH FORUM and the COMPAMED SUPPLIERS FORUM will be following important industry and technological trends and provide practical information related to new procedures, products and relevant aspects of work on international markets.
Related Links:
MEDICA
Latest Medica 2023 News
- Absology Showcases Latest Advancements in Medical Diagnostics
- Noul Showcases AI-Driven Blood and Cancer Diagnostic Platform
- Oruba Presents State-of-the-Art Self-Operating Uroflowmeters
- Awareness Technology Exhibits Incredibly Flexible ChemWell 2 ELISA and Chemiluminescent Analyzer
- BioVendor Group Demonstrates Unique IVD Platform and Immunoblot Test
- Greiner Bio-One Highlights Magnetic 3D Cell Culture Technology
- Fujirebio Showcases Range of Novel Testing Solutions
- Sentinel Diagnostics Demonstrates New SENTiNAT 200 and STAT-NAT Kits for Infectious Diseases
- DiaSys Showcases High Quality Diagnostic Reagents and System Solutions
- Randox Exhibits Full Range of Molecular Diagnostic Solutions
- Alcor Scientific Demonstrates Fully-Automated ESR Analyzers
- Bosch Healthcare Presents Vivalytic Point-of-Care PCR System
- CerTest Presents Innovations Related to VIASURE Products
- Vircell Highlights All-in-One CLIA System and Real Time PCR Kits
- Tianlong Showcases Cutting-Edge Products and Innovative Molecular Diagnostic Solutions
- Getein Biotech Exhibits Advanced POCT Analyzers
Channels
Clinical Chemistry
view channel
Gold Nanoparticles to Improve Accuracy of Ovarian Cancer Diagnosis
Ovarian cancer is considered one of the deadliest cancers, in part because it rarely shows clear symptoms in its early stages, and diagnosis is often complex. Current approaches make it difficult to accurately... Read more
Simultaneous Cell Isolation Technology Improves Cancer Diagnostic Accuracy
Accurate cancer diagnosis remains a challenge, as liquid biopsy techniques often fail to capture the complexity of tumor biology. Traditional systems for isolating circulating tumor cells (CTCs) vary in... Read moreMolecular Diagnostics
view channel
Blood Test Could Detect Proteins Linked to Alzheimer's Disease and Memory Loss
Alzheimer’s disease has long been associated with sticky amyloid plaques in the brain, but these markers alone do not fully explain the memory loss and cognitive decline patients experience.... Read more
Brain Inflammation Biomarker Detects Alzheimer’s Years Before Symptoms Appear
Alzheimer’s disease affects millions globally, but patients are often diagnosed only after memory loss and other symptoms appear, when brain damage is already extensive. Detecting the disease much earlier... Read more
First-of-Its-Kind Blood Test Detects Over 50 Cancer Types
Many cancers lack routine screening, so patients are often diagnosed only after tumors grow and spread, when options are limited. A faster, less invasive approach that broadens early detection could shift... Read more
Routine Blood Draws Could Detect Epigenetic Biomarkers for Predicting Cardiovascular Disease Risk
Cardiovascular disease is a leading cause of death worldwide, yet predicting individual risk remains a persistent challenge. Traditional risk factors, while useful, do not fully capture biological changes... Read moreHematology
view channel
Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments
Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more
Platelets Could Improve Early and Minimally Invasive Detection of Cancer
Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more
Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment
Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read moreImmunology
view channel
Novel Tool Uses Deep Learning for Precision Cancer Therapy
Nearly 50 new cancer therapies are approved each year, but selecting the right one for patients with highly individual tumor characteristics remains a major challenge. Physicians struggle to navigate the... Read more
Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients
Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read moreMicrobiology
view channel
Microfluidic Platform Assesses Neutrophil Function in Sepsis Patients
Sepsis arises from infection and immune dysregulation, with neutrophils playing a central role in its progression. However, current clinical tools are unable to both isolate these cells and assess their... Read more
New Diagnostic Method Confirms Sepsis Infections Earlier
Sepsis remains one of the most dangerous medical emergencies, often progressing rapidly and becoming fatal without timely intervention. Each hour of delayed treatment in septic shock reduces patient survival... Read more
New Markers Could Predict Risk of Severe Chlamydia Infection
Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Portable Spectroscopy Rapidly and Noninvasively Detects Bacterial Species in Vaginal Fluid
Vaginal health depends on maintaining a balanced microbiome, particularly certain Lactobacillus species. Disruption of this balance, known as dysbiosis, can increase risks of infection, pregnancy complications,... Read morePathology
view channel
Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma
Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more
Clinicopathologic Study Supports Exclusion of Cervical Serous Carcinoma from WHO Classification
High-grade serous carcinoma is a rare diagnosis in cervical biopsies and can be difficult to distinguish from other tumor types. Cervical serous carcinoma is no longer recognized as a primary cervical... Read moreTechnology
view channel
Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine
The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Rapid Diagnostic Technology Utilizes Breath Samples to Detect Lower Respiratory Tract Infections
Respiratory tract infections (LRTIs) are leading causes of illness and death worldwide, particularly among vulnerable populations such as the elderly, young children, and those with compromised immune systems.... Read moreIndustry
view channel
VedaBio Partners With Mammoth Biosciences to Expand CRISPR-Based Diagnostic Technologies
VedaBio (San Diego, CA, USA) has entered into a non-exclusive license agreement with Mammoth Biosciences (Brisbane, CA, USA) for the use of select CRISPR-based technologies in diagnostic applications.... Read more